Press Release

CREMER OLEO has become the holder of the first CEP ever granted for a Medium-Chain Triglyceride (MIGLYOL® 812 N).

Published

Format: PDF file | Document type: Press Release

Cremer Oleo
Download PDF Now!

may use your contact data to keep you informed of its products and services by email or by phone. You can withdraw your marketing consent at any time by clicking the unsubscribe link in such email or by sending an email to dataprivacy@wrbm.com
More information on our processing can be found in our Privacy Notice. By submitting this form, you acknowledge that you have read and understand our Privacy Notice.

CREMER OLEO has gathered its activities for the pharmaceutical industry under the roof of CREMER Health, with a strong commitment to quality leadership in Oleoceuticals. 

Our pharmaceutical excipients for topical, oral and rectal applications as well as our oleo-chemical based active pharmaceutical ingredients for enteral and parenteral applications have been enjoying a good reputation for decades. 

Our strict adherence to quality is underpinned and rewarded with the repeated granting of an EU GMP-certificate as well as the availability of several regulatory documentations (US DMFs / CEP). 

Supplier info centre